By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



111 West Lemon Avenue

Monrovia  California  91016  U.S.A.
Phone: 626-305-5900 Fax: 626-305-0350



Drug Discovery

Company News
Xencor To Host Second Quarter 2014 Financial Results Webcast And Conference Call 7/24/2014 10:44:15 AM
Xencor Appoints Kurt Gustafson To Board Of Directors; Promotes John Desjarlais To Chief Scientific Officer 7/15/2014 9:51:10 AM
Xencor Initiates Phase 1 Study Of XmAb7195 For Asthma 5/28/2014 9:04:44 AM
Xencor To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/22/2014 7:02:45 AM
Xencor Presents Study Comparing XmAb7195 To Omalizumab At The American Thoracic Society 2014 International Conference 5/15/2014 7:42:16 AM
Xencor Reports First Quarter 2014 Financial Results 5/15/2014 6:21:35 AM
Xencor To Host First Quarter 2014 Financial Results Webcast And Conference Call 5/7/2014 7:08:48 AM
Xencor To Present At Deutsche Bank (DB) 39th Annual Health Care Conference 4/29/2014 9:26:18 AM
Xencor Receives Milestone Payment From Merck & Co., Inc. (MRK) For Initiation Of Phase 1 Clinical Trial Of A Biologic Candidate Using XmAb® Antibody Engineering Intellectual Property 4/11/2014 9:12:31 AM
Xencor Showcases Bispecific Antibody Programs At Annual Summit On Practical And Emerging Trends In Multiple Myeloma 3/28/2014 9:16:47 AM